CoChat

Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94

Open access
A. Ansa-Addo, Ephraim, Thaxton, Jessica, Hong, Feng, X. Wu, Bill, Zhang, Yongliang, W. Fugle, Caroline, Metelli, Alessandra, Riesenberg, Brian, Williams, Katelyn, T. Gewirth, Daniel, Chiosis, Gabriela, Liu, Bei, Li, Zihai · 2016 · Current Topics in Medicinal Chemistry
Cited by 102

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

As an endoplasmic reticulum heat shock protein (HSP) 90 paralogue, glycoprotein (gp) 96 possesses immunological properties by chaperoning antigenic peptides for activation of T cells. Genetic studies in the last decade have unveiled that gp96 is also an essential master chaperone for multiple receptors and secreting proteins including Toll-like receptors (TLRs), integrins, the Wnt coreceptor, Low Density Lipoprotein Receptor-Related Protein 6 (LRP6), the latent TGFβ docking receptor, Glycoprotein A Repetitions Predominant (GARP), Glycoprotein (GP) Ib and insulin-like growth factors (IGF). Clinically, elevated expression of gp96 in a variety of cancers correlates with the advanced stage and poor survival of cancer patients. Recent preclinical studies have also uncovered that gp96 expression is closely linked to cancer progression in multiple myeloma, hepatocellular carcinoma, breast cancer and inflammation-associated colon cancer. Thus, gp96 is an attractive therapeutic target for cancer treatment. The chaperone function of gp96 depends on its ATPase domain, which is structurally distinct from other HSP90 members, and thus favors the design of highly selective gp96-targeted inhibitors against cancer. We herein discuss the strategically important oncogenic clients of gp96 and their underlying biology. The roles of cell-intrinsic gp96 in T cell biology are also discussed, in part because it offers another opportunity of cancer therapy by manipulating levels of gp96 in T cells to enhance host immune defense.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1568026616666160413141613

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 102

Metadata

Authors
A. Ansa-Addo, E., Thaxton, J., Hong, F., X. Wu, B., Zhang, Y., W. Fugle, C., Metelli, A., Riesenberg, B., Williams, K., T. Gewirth, D., Chiosis, G., Liu, B., & Li, Z.
Venue
Current Topics in Medicinal Chemistry
Published
2016-08-16
Volume
16
Issue
25
Pages
2765-2778
ISSN
1568-0266 (ISSN-L)
OpenAlex
W2336550720
Cited by
102
References
10
FWCI
4.82
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94. https://app.cochat.ai/papers/10.2174/1568026616666160413141613
The paper
A. Ansa-Addo, E., Thaxton, J., Hong, F., X. Wu, B., Zhang, Y., W. Fugle, C., Metelli, A., Riesenberg, B., Williams, K., T. Gewirth, D., Chiosis, G., Liu, B., & Li, Z. (2016). Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/1568026616666160413141613

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.